Use of cidofovir in pediatric patients with adenovirus infection

Background: Adenoviruses contribute to morbidity and mortality among immunocompromised pediatric patients including stem cell and solid organ transplant recipients. Cidofovir (CDV), an antiviral compound approved by the FDA in 1996, is used for treatment of adenoviral (ADV) infections in immunocompr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganapathi, Lakshmi, Arnold, Alana, Jones, Sarah, Patterson, Al, Graham, Dionne, Harper, Marvin, Levy, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863673/
https://www.ncbi.nlm.nih.gov/pubmed/27239277
http://dx.doi.org/10.12688/f1000research.8374.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863673/
https://www.ncbi.nlm.nih.gov/pubmed/27239277
http://dx.doi.org/10.12688/f1000research.8374.2

Ejemplares similares